首页> 外文期刊>The Turkish journal of pediatrics >Thymic output changes in children with clinical findings signaling a probable primary immunodeficiency
【24h】

Thymic output changes in children with clinical findings signaling a probable primary immunodeficiency

机译:临床调查患儿的胸腺输出变化,信号发出可能的主要免疫缺陷

获取原文
获取原文并翻译 | 示例
       

摘要

Thymic maturation evaluation is inevitable for patients with clinical and laboratory findings for a primary immunodeficiency, as the T cell-immunodeficiencies are the most severe type. In this study, we aimed to show the usage of T cell surface molecule "CD31" for the evaluation of thymic output in patients (n: 66) with a large spectrum of findings signing a probable primary immunodeficiency. Besides the classical clinical and laboratory approach for these patients, T cell subpopulations as naive, memory, recent thymic emigrant cells were also investigated. The humoral immunodeficiency (34.8%), combined immunodeficiency (34.8%) and cardiopathy (7.6%) were the most frequent diagnosis groups. CD4+CD45RA+ naive T-cells percentages (p: 0.011) and absolute counts (p: 0.004) and absolute CD4+CD45RA+CD31 + RTE (recent thymic emigrant) cell counts (p: 0.007) were significantly lower in combined immunodeficiency group. Naive T-cells (p: 0.037) and RTE cells (p: 0.032) were also lower in patients who had cardiac surgery in the past. In conclusion, flow cytometric CD31+thymic naive RTE cell evaluation may provide rapid clinical information especially on T-cell immune dysfunction and CD4+CD45RA+CD31+ RTE cells may be used as an alternative to TRECs in the diagnosis of combined immunodeficiencies.
机译:由于T细胞免疫缺陷是最严重的一种类型,对于有原发性免疫缺陷临床和实验室检查结果的患者,胸腺成熟度评估是不可避免的。在这项研究中,我们的目的是展示T细胞表面分子“CD31”在评估可能存在原发性免疫缺陷的患者(n:66)的胸腺输出中的应用。除了针对这些患者的经典临床和实验室方法外,还研究了T细胞亚群,如幼稚、记忆、近期胸腺移行细胞。体液免疫缺陷(34.8%)、联合免疫缺陷(34.8%)和心脏病(7.6%)是最常见的诊断组。联合免疫缺陷组的CD4+CD45RA+幼稚T细胞百分比(p:0.011)、绝对计数(p:0.004)和绝对CD4+CD45RA+CD31+RTE(近期胸腺移植物)细胞计数(p:0.007)显著降低。在过去接受过心脏手术的患者中,原始T细胞(p:0.037)和RTE细胞(p:0.032)也较低。总之,流式细胞术CD31+胸腺原始RTE细胞评估可提供快速的临床信息,尤其是关于T细胞免疫功能障碍的信息,CD4+CD45RA+CD31+RTE细胞可作为联合免疫缺陷诊断中TRECs的替代物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号